Changes in antibody levels and clinical findings in patients with lupus nephritis.
- Sachiko Onishi (758532)
- Endy Adnan (758533)
- Jun Ishizaki (758534)
- Tatsuhiko Miyazaki (28386)
- Yuki Tanaka (112000)
- Takuya Matsumoto (36535)
- Koichiro Suemori (236240)
- Masachika Shudou (758535)
- Takafumi Okura (588813)
- Hiroyuki Takeda (247055)
- Tatsuya Sawasaki (29885)
- Masaki Yasukawa (28387)
- Hitoshi Hasegawa (28382)
Publication date
June 2015
DOIAbstract
<p>▲ LN1, ♦ LN2, ● LN3, ◊ LN4, ○ LN5, □ LN6, ■ LN7. <b>(A)</b> Anti-RRP8 antibody, <b>(B)</b> anti-TNP1 antibody, <b>(C)</b> SLEDAI, <b>(D)</b> anti-dsDNA antibody, <b>(E)</b> C3, and <b>(F)</b> C4. The active and inactive phases of LN were defined as 4≤ and 0 of the renal SLEDAI score, respectively.</p
Add to ORKG